No Data
Guangzheng Eye Hospital Raises Unit's Capital to 100 Million Yuan
Guangzheng Ophthalmology: 2024 performance forecast
Shareholders in Guangzheng Eye Hospital GroupLtd (SZSE:002524) Have Lost 62%, as Stock Drops 16% This Past Week
Guangzheng Ophthalmology: Report for the third quarter of 2024
Guangzheng Eye Hospital Group (002524.SZ) released its performance for the first three quarters, with a net loss of 20.8086 million yuan.
Guangzheng Eye Hospital Group (002524.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...
guangzheng eye hospital group (002524.SZ): a net loss of 20.8086 million yuan in the first three quarters.
Guangzheng Eye Hospital Group (002524.SZ) announced its third quarter report for 2024 on October 24. In the first three quarters of 2024, the company achieved revenue of 0.699 billion yuan, a decrease of 15.49% year-on-year; net income attributable to shareholders of the listed company suffered a loss of 20.8086 million yuan, a decrease of 299.40% year-on-year; net income, excluding non-recurring gains and losses, suffered a loss of 29.4314 million yuan, a decrease of 1150.98% year-on-year; basic earnings per share incurred a loss of 0.04 yuan per share.
Guangzheng Eye Hospital Group Co., Ltd.'s (SZSE:002524) 26% Share Price Surge Not Quite Adding Up
